IFNG and plasma cell myeloma: The unique cytokine profile, the in vitro increase in IFN-γ production in the presence of checkpoint blockade, as well as the requirement of checkpoint blockade for in vivo anti-myeloma immunity, suggest that PD-1+ T cells are functionally impaired, but the dysfunctional state can be reversed to provide anti-myeloma immunity [20].